Research Article

Obesity Is an Independent Predictor of Poor Survival in Metastatic Breast Cancer: Retrospective Analysis of a Patient Cohort Whose Treatment Included High-Dose Chemotherapy and Autologous Stem Cell Support

Figure 2

Overall survival (OS) from diagnosis (a) and from time of metastasis (b) and progression-free survival (PFS) from diagnosis (c) and from time to metastasis (d) in patients with a BMI ≤ 30 ( 𝑛 = 7 3 ) or >30 ( 𝑛 = 2 3 ). Survival was estimated using Kaplan-Meier method.
523276.fig.002a
(a) OS from initial diagnosis
523276.fig.002b
(b) OS from metastasis
523276.fig.002c
(c) PFS from initial diagnosis
523276.fig.002d
(d) PFS from metastasis